News | April 16, 2025
Rising Pharma gets final approval from USFDA for Mesalamine Suppositories 1000 mg
The approved product, Mesalamine Suppositories 1000 mg, has an estimated U.S. market size of US$ 29 million
The approved product, Mesalamine Suppositories 1000 mg, has an estimated U.S. market size of US$ 29 million
Before joining Sun Pharma, Tulla served as Senior Vice President and Chief Commercial Head – Acute Cluster at Cipla
The company does not expect this development to have any material impact on the current business operations
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
Apitoria Pharma’s API manufacturing facility classified as VAI by USFDA
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company’s commitment to advancing respiratory care in India
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
VITADEETM Green is a 100% plant-based Vitamin D3 suitable for food & nutraceuticals
The observations issued are neither repeated observations nor related to data integrity
Subscribe To Our Newsletter & Stay Updated
